美国贝勒医学院博士后职位—遗传流行病学
美国贝勒医学院博士后职位—遗传流行病学
贝勒医学院(Baylor College of Medicine)是美国休斯敦的一所私立医药学校,被认为是全美最杰出的医学院之一,获中国教育部认证。学校在世界范围内的生物医药研究领域处于领先地位,学校最早建立于一九零零年,迄今为止已经有一百多年的悠久历史了。
贝勒医学院为学生提供财政援助和奖学金,帮助学生减轻就学期间的经济压力,符合要求的学生都可以申请奖学金和财政援助。学校致力于医药和研究生教育,并且因而获得了超过一亿美金的捐赠,是美国六十三所获得超过一亿捐赠的优秀大学之一。
Postdoctoral Associate- Genetic Epidemiology
Baylor College of Medicine
Job Description
Summary
The Section of Epidemiology and Population Sciences at Baylor College of Medicine invites applications for postdoctoral research in systems epidemiology of cancer.
This is a 3-year flexible program with personalized educational curricula and individually tailored multidisciplinary teams of mentors with ongoing research in a variety of pediatric and adult cancers. The training provides epidemiology and bioinformatics fellows with the specialized skills to incorporate novel high-throughput technologies into large-scale collaborative epidemiology studies and to become successful, cross-trained researchers. Exciting opportunities also exist to work with faculty from MD Anderson Cancer Center, Rice University and UTHealth School of Biomedical Informatics.
Job Duties
Analyzes large data sets.
Analyzes next generation sequencing data (e.g., RNA-seq, whole genome/ exome sequencing).
Uses state-of-the-art bioinformatical and statistical tools.
Develops new statistical methods to answer biological questions that arise in the research.
Develops the ability to work in a team environment.
Minimum Qualifications
MD or Ph.D. in Basic Science, Health Science, or a related field.
No experience required.
Preferred Qualifications
Ph.D. epidemiologists or bioinformaticians or M.D.s/DVMs with related experience.
Other qualifications include excellent writing skills in English.
Prior experience with next generation sequencing data analysis is a plus.
Knowledge in cancer biology or genetics is preferable.
Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.
准备申请国外博士后的各位老师注意了!知识人网(www.zsrw.cn)小编每周定时更新最新的国内外博士后招聘信息以及访问学者、博士后资讯,感谢大家的关注!